Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-12 |
filingDate |
2005-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fb8e7da4201b4655c7331cdf661bf3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09cf776842e511bd4a18025cbf223aaf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3494b0f678d62fcb112e3d8e95a8ef9 |
publicationDate |
2005-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
NO-20054002-L |
titleOfInvention |
Treatment for diarrhea-predominantly irritable bowel syndrome |
abstract |
Pharmaceutical composition for anti-diarrheal irritable tooth syndrome in male and female patients, containing from 0.001 to 0.05 mg of ramosetron hydrochloride as a daily dose or an equivalent mole amount of ramosetron or its pharmaceutically acceptable other salt as an active ingredient |
priorityDate |
2004-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |